Orphan Drug Markets in Europe
11/1/2011 | published by: Urch Publishing
... drugs in Europe took place a decade ago. Since then there have been over 60 designated orphan products. These products now account for annual sales of more than $6 billion. Traditionally the development and marketing ...
|
more...
|
$2,900.00
|
|
|
$2,345.00
|
Pharmaceutical Market Trends, 2010 - 2014
10/1/2010 | published by: Urch Publishing
... from URCH Publishing, presents a series of market forecasts and growth opportunities in order to help inform pharmaceutical decision-making, particularly in the areas of corporate planning, portfolio management and market forecasting. The report is divided ...
|
more...
|
$2,345.00
|
The Future of European Pharmaceutical Distribution
7/1/2010 | published by: Urch Publishing
... dramatically over the next few years. The adoption of direct-to-pharmacy (DTP) in the UK and its emergence in Poland sets a potential precedent for other European markets. To date, pharmaceutical manufacturers have managed to drive ...
|
more...
|
$2,975.00
|
Biosimilars: A Growing Market
3/1/2010 | published by: Urch Publishing
... there has been a steady breakdown of regulatory resistance. However, there are considerable entry barriers hindering companies that wish to enter this field of therapeutics. Biosimilars - A Growing Market is a unique report from ...
|
more...
|
$2,345.00
|
Pharmaceutical Distribution in the US
7/1/2009 | published by: Urch Publishing
... have made increasing efforts to protect the national supply chain for medicines distribution. Since it represents the means for medicines to reach patients, any breaches in the system would be catastrophic and could affect millions ...
|
more...
|
$2,345.00
|
Generic Competition 2009 to 2013
4/1/2009 | published by: Urch Publishing
... Lipitor and Plavix are now expected toface generic competition. The period 2009-13 will see major companies facing very different degrees of exposure to the potential loss of revenue to generics. Eli Lilly, Pfizer, Bristol-Myers Squibb, ...
|
more...
|
$1,650.00
|
Mergers and Acquisitions in the Pharmaceuticals Sector
4/1/2009 | published by: Urch Publishing
... and Warner-Lambert (2000) - the acquisition of Wyeth would provide a broad and diversified portfolio, rather than been focused on a single product or cost-cutting. Pfizer’s strategy of growing its portfolio through a mega M&A ...
|
more...
|
$1,620.00
|
Major Pharmaceutical Markets of the Middle East
2/14/2009 | published by: Urch Publishing
... to become self-sufficient in pharmaceuticals production.” Major Pharmaceutical Markets of the Middle East (2nd Edition) is a comprehensive report providing extensive coverage of one of the strongest emerging markets. Through quality analysis and forecasts, this ...
|
more...
|
$2,030.00
|
Manufacturing in the Global Pharmaceuticals Industry
9/1/2008 | published by: Urch Publishing
... ed) is the only report available that covers this crucial area of the pharmaceutical industry in such depth. The concentration in recent years on creating organisations that are market or customer-led, or research-driven has taken ...
|
more...
|
$1,465.00
|
|
|
$1,975.00
|
|
|
$2,699.00
|
Pharmaceutical Market Trends, 2007 - 2011
11/1/2007 | published by: Urch Publishing
... made using a five-year future time period. Thus, the data and analysis relate to the nine-year time horizon from 2003 to 2011. All data used in outlining historical trends is clearly sourced within the report ...
|
more...
|
$2,078.00
|
|
|
$1,811.23
|
CNS Market Trends, 2007 to 2010
6/1/2007 | published by: Urch Publishing
... increased by 19% and accounted for 9.2% of total global pharmaceutical sales in 2005. Annual global CNS sales growth slowed from 11.5% in 2004 to 6.6% in 2005 as a result of generic competition for ...
|
more...
|
$2,110.00
|
Cancer Market Trends 2006 - 2010
12/1/2006 | published by: Urch Publishing
... global pharmaceutical sales. Although growth rates for this market will slow due to generic competition the market is predicted to expand to $85.3 billion by 2010 equivalent to CAGR of 11.1% Cancer Market Trends, 2006-2010 ...
|
more...
|
$2,071.00
|
|
|
$1,791.00
|
Preparing Health Technology Submissions for Pharmaceutical Products
4/1/2006 | published by: Urch Publishing
... make a convincing case to the regulators The rapid uptake of formulary submission guidelines in the last decade is forcing pharmaceutical manufacturers and biotechnology companies to comply with more rigorous evidentiary and analytical standards in ...
|
more...
|
$2,790.00
|
|
|
$1,746.00
|
Pricing & Reimbursement of Medicines in the United Kingdom
6/1/2005 | published by: Urch Publishing
... operates and sells its products. The Pricing & Reimbursement of Medicines in the United Kingdom - Understanding the pharmaceutical market in the healthcare system is a straightforward guide to the pricing and reimbursement mechanisms in ...
|
more...
|
$810.00
|
Pharmaceutical Pricing
9/1/2004 | published by: Urch Publishing
... must not be left to luck. If the price is set too high, the product may fail to gain reimbursement or be excluded from formularies. If the price is too low, profitability will be reduced. ...
|
more...
|
$1,170.00
|
Global Pharmaceutical Fine Chemicals
7/1/2004 | published by: Urch Publishing
... serve the various sub-sectors of the pharmaceutical industry and what factors will affect the industry. This unique document will give you and your organisation the knowledge of how pharmaceutical fine chemicals are manufactured and sold, ...
|
more...
|
$1,665.00
|
Research & Development in the Pharmaceutical Industry
2/1/2004 | published by: Urch Publishing
... report that provides the latest information and insight into pharmaceutical industry research and development issues. This report analyses the key issues affecting a pharmaceutical company’s success in the search for and development of new drugs.
|
more...
|
$1,431.00
|
Parallel Trade in Pharmaceuticals
10/1/2003 | published by: Urch Publishing
... at different prices in different markets, there is an incentive for those wishing to reduce the costs of their purchases to seek these products from the lower-priced markets. As the demand for cheaper products has ...
|
more...
|
$1,071.00
|
Opportunities in Drug Delivery
9/1/2003 | published by: Urch Publishing
... of companies wishing to improve convenience of their delivery to the patient. Drug delivery will play an increasingly important role in the next decade as more macromolecules including proteins, peptides and oligonucleotides find their way ...
|
more...
|
$720.00
|